COSM · Cosmos Health Inc.
$0.18
-0.01 (-6.11%)
At close · Jul 29
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the date of this filing.”View the 10-Q filed May 20, 2026
Market Cap
$9.94M
Shares
54.43M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$65.27M
+19.9%
FY2025
Net Income
-$19.14M
-18.3%
FY2025
Gross Margin
12.1%
+4.2pp
FY2025
Operating Margin
-25.59%
+3pp
FY2025
Diluted EPS
-$0.63
+46.2%
FY2025
Operating Cash Flow
-$8.45M
-9.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $69.49M | $65.27M | $54.43M | $53.38M | $50.35M | $56.24M | $55.41M | $39.68M | $37.08M | $30.01M | $6.76M | $533.8K | $7.64M | $902.37K | — | |
| — | — | — | — | — | — | — | — | — | — | — | $1063 | $433 | — | — | |
| $62.26M | $57.38M | $50.12M | $49.03M | $44.39M | $47.91M | $47.35M | $36.01M | $34.68M | $28.06M | $6.15M | $484.81K | — | — | — | |
| $7.23M | $7.9M | $4.31M | $4.35M | $5.96M | $8.33M | $8.06M | $3.66M | $2.41M | $1.96M | $601.04K | $48.99K | $7.64M | — | — | |
| — | 12.1% | 7.92% | 8.15% | 11.83% | 14.81% | 14.55% | 9.23% | 6.5% | 6.52% | 8.9% | 9.18% | 100% | — | — | |
| $503.73K | $519.36K | $533.29K | $164.86K | — | — | — | — | — | — | — | — | — | — | — | |
| $141.44K | $150.24K | $354.97K | $1.2M | $630.06K | $732.55K | $763.17K | $234.04K | — | — | — | — | — | — | — | |
| $15.94M | $15.62M | $11.73M | $19.64M | $10.18M | $9.21M | $2.1M | $3.29M | $3.59M | $4.85M | $794.1K | $486.04K | $442.96K | $56.16K | $455 | |
| $940.81K | $925.11K | $793.84K | $239.84K | $33.09K | $33.09K | $33.18K | $33.09K | $9307 | $8533 | $0 | — | — | — | — | |
| $1.39M | $1.36M | $1.22M | $614.38K | $103.19K | $352.42K | $397.6K | $394.63K | $43.93K | — | — | — | — | — | — | |
| $25.28M | $24.6M | $19.86M | $26.18M | $13.43M | $12.86M | $5.35M | $3.92M | $3.64M | $6.83M | $803.55K | $491.45K | $523.31K | — | — | |
| -$18.05M | -$16.7M | -$15.54M | -$21.83M | -$7.47M | -$4.53M | $2.71M | -$255.81K | -$1.23M | -$4.87M | -$202.51K | -$442.46K | $7.12M | $288.71K | -$455 | |
| — | -25.59% | -28.56% | -40.9% | -14.84% | -8.06% | 4.9% | -0.64% | -3.31% | -16.23% | -3% | -82.89% | 93.15% | 31.99% | — | |
| -$16.66M | -$15.34M | -$14.33M | -$21.22M | -$7.37M | -$4.18M | $3.11M | $138.82K | -$1.18M | — | — | — | — | — | — | |
| $2.14M | $1.9M | $1.01M | $866.48K | $2.35M | $2.82M | $2.76M | -$1.41M | -$967.82K | $748.47K | $189.69K | $86.9K | $63.52K | — | — | |
| — | — | — | — | — | — | $65.87K | $0 | — | — | — | — | — | $52 | $52 | |
| -$3.08M | -$2.44M | -$638.19K | $3.29M | -$5.58M | -$3.31M | -$1.52M | -$2.86M | -$7.81M | — | — | — | — | — | — | |
| $6161 | — | $2470 | $4584 | $1676 | — | — | $4381 | $2.5M | — | — | -$6.15M | — | — | — | |
| -$21.13M | -$19.14M | -$16.18M | -$18.54M | -$13.06M | -$7.85M | $1.2M | -$3.12M | -$9.04M | -$6.21M | -$600.23K | -$6.69M | $7.04M | $286.27K | -$455 | |
| $0 | $0 | $0 | $0 | -$775.05K | $114.01K | -$377.54K | $182.82K | -$17.33K | $2801 | $769 | $203 | $997.18K | $39.68K | — | |
| -$21.13M | -$19.14M | -$16.18M | -$18.54M | -$13.83M | -$7.96M | $820.79K | -$3.3M | -$9.06M | -$6.21M | -$601K | -$6.69M | $6.04M | $246.59K | -$455 | |
| — | -29.33% | -29.73% | -34.74% | -27.47% | -14.16% | 1.48% | -8.31% | -24.43% | -20.69% | -8.9% | -1252.88% | 79.13% | 27.33% | — | |
| — | — | -$22.38M | -$25.78M | -$63.95M | — | — | — | — | — | — | — | — | — | — | |
| -$19.99M | -$16.68M | -$24.09M | -$25.07M | -$64.93M | -$16.6M | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $0.06 | -$0.25 | -$0.68 | -$0.49 | $0.00 | -$0.05 | $0.05 | $0.00 | $0.00 |
| USD/shares | — | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $0.06 | -$0.25 | -$0.68 | -$0.49 | $80,741.00 | -$0.05 | $0.05 | $0.00 | $0.00 |
| shares | — | 30.29M | 19.15M | 11.97M | 1.93M | 656.93K | 13.27M | 13.27M | 13.31M | 12.78M | 12.56M | 125.62M | 125.59M | 106.68M | 100M |
| shares | — | 30.29M | 19.15M | — | 1.93M | 656.93K | 13.31M | 13.27M | 13.31M | 12.78M | 125.65M | 125.62M | 125.8M | 106.74M | 100M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2024: $677.32K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Medical Distribution median 24.41×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Wholesale | $59,318,982 | $51,593,787 | $50,744,468 |
| Nutraceuticals and Pharmaceuticals | $4,262,543 | $1,967,242 | $2,287,698 |
| Pharmamanufacturing | $1,689,062 | $865,373 | $344,708 |
| Other | $1,228 | $0 | $0 |